SCHEMBL2656441

SCHEMBL2656441

Cc1cc(SCCCCCc2ccc(C(=O)O)s2)cc(C)c1-c1ccc(C(C)(C)C)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 9/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
PRNP P04156 1/20 0.37
RECQL P46063 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GRIA2 P42262 5/20 0.35
PTGER3 P43115 1/20 0.35
PTGER2 P43116 1/20 0.35
PTGDR Q13258 1/20 0.35
MAPT P10636 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
HPGD P15428 1/20 0.33
THRB P10828 1/20 0.33
GRIN2C Q14957 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655551 0.99 GRIA4 (0.39) GRIA4ALDH1A1LMNAPRNPRECQL
SCHEMBL2655577 0.96 GRIA4 (0.39) GRIA4ALDH1A1LMNAPRNPRECQL
SCHEMBL2655215 0.91 PPARD (0.39) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL2655627 0.90 PPARD (0.39) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL2652568 0.87 PPARD (0.40) PPARDPPARA
SCHEMBL2652959 0.86 GCGR (0.43) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL2653596 0.85 GCGR (0.44) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL2658618 0.84 GRIA4 (0.37) GRIA4ALDH1A1GRIA2PTGER3PTGER2
SCHEMBL2653026 0.82 GCGR (0.44) ALDH1A1LMNAPRNPRECQLRXFP1
SCHEMBL2655641 0.82 GRIA4 (0.36) GRIA4ALDH1A1GRIA2PTGER3PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957484-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Eli Lilly & Company (US) 2008-08-20 EP claimed
WO-2007120284-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-10-25 WO claimed
EP-1957484-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Eli Lilly & Company (US) 2008-08-20 EP disclosed
WO-2007120284-A2 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-10-25 WO disclosed